{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T04:21:35Z","timestamp":1770697295035,"version":"3.49.0"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p>Evidences for the personalized use of nonsteroidal anti-inflammatory drugs (NSAIDs) in colorectal cancer (CRC) prevention and treatment that include consideration of prostaglandin E<jats:sub>2<\/jats:sub> levels are necessary. This study was designed as a case-control study including 60 CRC patients and 120 cancer-free controls. A sensitive empirical method, precolumn derivatization HPLC, was used to determine plasma PGE<jats:sub>2<\/jats:sub> levels. The TaqMan SNP Genotyping Assay was used for the genotyping of prostaglandin-endoperoxide synthase 2 (PTGS2) polymorphisms. Multivariate logistic regression analysis suggested that 1 log<jats:sub>10<\/jats:sub>(PGE<jats:sub>2<\/jats:sub>) increase would result in a 3.64-fold increase in the risk of CRC. Moreover, subjects with log<jats:sub>10<\/jats:sub>(PGE<jats:sub>2<\/jats:sub>) level in the 75th percentile had a significantly higher risk of CRC than those with log<jats:sub>10<\/jats:sub>(PGE<jats:sub>2<\/jats:sub>) levels in the 25th percentile [odds ratio (OR), 3.50; 95% confidence interval (CI), 1.35\u22129.05]. This association was more evident after adjustment for history of NSAIDs use (OR, 3.85; 95% CI, 1.46\u221210.16). Preliminarily, 260.02 and 414.95 pg\/ml might be proposed as the preventive and warning cutoff values of plasma PGE<jats:sub>2<\/jats:sub> for CRC. The preferred NSAIDs dose for patients with the AG+GG (rs689466) and CC+CT (rs5275) genotypes should be higher than that of patients carrying AA or TT genotypes, despite the presence of equal plasma PGE<jats:sub>2<\/jats:sub> levels. We show for the first time that the plasma PGE<jats:sub>2<\/jats:sub> level is associated with the risk of CRC. We provide a preliminary suggestion for NSAIDs doses adjustment according to PTGS2 genotypes after consideration of plasma PGE<jats:sub>2<\/jats:sub> levels.<\/jats:p>","DOI":"10.1097\/cej.0000000000000583","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T05:03:53Z","timestamp":1587013433000},"page":"59-68","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Association between plasma prostaglandin E2 level and colorectal cancer"],"prefix":"10.1097","volume":"30","author":[{"given":"Fan","family":"Wang","sequence":"first","affiliation":[{"name":"Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maoqing","family":"Wang","sequence":"additional","affiliation":[{"name":"Nutrition and Food Hygiene, School of Public Health, Harbin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huihui","family":"Yin","sequence":"additional","affiliation":[{"name":"Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Long","sequence":"additional","affiliation":[{"name":"Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Yu","sequence":"additional","affiliation":[{"name":"Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongru","family":"Sun","sequence":"additional","affiliation":[{"name":"Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoran","family":"Bi","sequence":"additional","affiliation":[{"name":"Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuying","family":"Li","sequence":"additional","affiliation":[{"name":"Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yashuang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinshu","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The Forth Affiliated Clinical Medical College of Harbin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junde","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"key":"R1-20250527","first-page":"91","article-title":"Effect of diet, life style, and other environmental\/chemopreventive factors on colorectal cancer development, and assessment of the risks.","volume":"22","author":"Ahmed","year":"2004","journal-title":"J Environ Sci Health C Environ Carcinog Ecotoxicol Rev"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00262-011-1174-4","article-title":"Regulatory T-cell-mediated inhibition of antitumor immune responses is associated with clinical outcome in patients with liver metastasis from colorectal cancer.","volume":"61","author":"Brudvik","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1200\/JCO.2006.06.4931","article-title":"Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk.","volume":"24","author":"Cai","year":"2006","journal-title":"J Clin Oncol"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.dld.2016.07.008","article-title":"Total and cancer mortality in a cohort of ulcerative colitis and Crohn\u2019s disease patients: The Florence inflammatory bowel disease study, 1978\u20132010.","volume":"48","author":"Caini","year":"2016","journal-title":"Dig Liver Dis"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1053\/j.gastro.2010.01.057","article-title":"Primary prevention of colorectal cancer.","volume":"138","author":"Chan","year":"2010","journal-title":"Gastroenterology"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa067208","article-title":"Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.","volume":"356","author":"Chan","year":"2007","journal-title":"N Engl J Med"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.2009.1112","article-title":"Aspirin use and survival after diagnosis of colorectal cancer.","volume":"302","author":"Chan","year":"2009","journal-title":"JAMA"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1158\/1940-6207.CAPR-11-0391","article-title":"Aspirin in the chemoprevention of colorectal neoplasia: an overview.","volume":"5","author":"Chan","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"e02210","DOI":"10.1128\/mBio.02210-15","article-title":"Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota.","volume":"7","author":"Chen","year":"2016","journal-title":"MBio"},{"key":"R10-20250527","first-page":"332","article-title":"COX-2 selective inhibitors cardiac toxicity: getting to the heart of the matter.","volume":"7","author":"Davies","year":"2004","journal-title":"J Pharm Pharm Sci"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-2407-9-207","article-title":"Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer.","volume":"9","author":"Doherty","year":"2009","journal-title":"BMC Cancer"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-146-5-200703060-00009","article-title":"The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive services task force.","volume":"146","author":"Dub\u00e9","year":"2007","journal-title":"Ann Intern Med"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/01.rhu.0000128851.12010.46","article-title":"Risk of upper gastrointestinal injury and events in patients treated with cyclooxygenase (COX)-1\/COX-2 nonsteroidal antiinflammatory drugs (nsaids), COX-2 selective nsaids, and gastroprotective cotherapy: an appraisal of the literature.","volume":"10","author":"Dubois","year":"2004","journal-title":"J Clin Rheumatol"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/clinchem\/47.4.624","article-title":"Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?","volume":"47","author":"Duffy","year":"2001","journal-title":"Clin Chem"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"i6188","DOI":"10.1136\/bmj.i6188","article-title":"Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis.","volume":"355","author":"Dulai","year":"2016","journal-title":"BMJ"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1097\/CCM.0b013e3181843d69","article-title":"Selective COX-2 inhibitors: new insights into mechanisms of side effects?","volume":"36","author":"Flier","year":"2008","journal-title":"Crit Care Med"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10552-008-9286-7","article-title":"Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a danish cohort study.","volume":"20","author":"Friis","year":"2009","journal-title":"Cancer Causes Control"},{"key":"R18-20250527","first-page":"2330","article-title":"Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1.","volume":"63","author":"Fukuda","year":"2003","journal-title":"Cancer Res"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1053\/j.gastro.2003.11.013","article-title":"Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis.","volume":"126","author":"Giardiello","year":"2004","journal-title":"Gastroenterology"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1749-6632.2000.tb06564.x","article-title":"Proinflammatory signals upregulate COX-2 and increase PGE2 production in biphenotypic B\/macrophage cells.","volume":"905","author":"Graf","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1096\/fj.01-0299fje","article-title":"COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.","volume":"15","author":"Gr\u00f6sch","year":"2001","journal-title":"FASEB J"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0029-1242458","article-title":"Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors.","volume":"22","author":"Haggar","year":"2009","journal-title":"Clin Colon Rectal Surg"},{"key":"R23-20250527","first-page":"4581","article-title":"Selective COX-2 inhibitors\u2013side effects in relation to non-specific non-steroidal anti-inflammatory drugs.","volume":"166","author":"Hansen","year":"2004","journal-title":"Ugeskr Laeger"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.plefa.2007.05.006","article-title":"Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells.","volume":"77","author":"Hazra","year":"2007","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1158\/1535-7163.1031.3.8","article-title":"Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer?","volume":"3","author":"Hull","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(03)13915-3","article-title":"Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.","volume":"362","author":"Huls","year":"2003","journal-title":"Lancet"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/0022034508329519","article-title":"PGE2 production in oral cancer cell lines is COX-2-dependent.","volume":"88","author":"Husvik","year":"2009","journal-title":"J Dent Res"},{"key":"R28-20250527","first-page":"90","article-title":"Immunochemical measurement of prostaglandin or prostaglandin-like activity from normal and neoplastic cultured tissue.","volume":"22","author":"Jaffe","year":"1971","journal-title":"Surg Forum"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.cgh.2006.07.015","article-title":"Urine PGE-M: a metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia.","volume":"4","author":"Johnson","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R30-20250527","first-page":"5136","article-title":"Intestinal immune responses in wild-type and apcmin\/+ mouse, a model for colon cancer.","volume":"63","author":"Kettunen","year":"2003","journal-title":"Cancer Res"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0025-7753(02)72344-0","article-title":"Gastrointestinal and cardiovascular side effects associated with COX-2 selective inhibitors.","volume":"118","author":"Lanas","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"R32-20250527","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2174\/138920012803341384","article-title":"Aspirin as a chemoprevention agent for colorectal cancer.","volume":"13","author":"Lee","year":"2012","journal-title":"Curr Drug Metab"},{"key":"R33-20250527","doi-asserted-by":"crossref","first-page":"G673","DOI":"10.1152\/ajpgi.00584.2006","article-title":"PGE2 inhibits apoptosis in human adenocarcinoma caco-2 cell line through ras-PI3K association and camp-dependent kinase A activation.","volume":"293","author":"Leone","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R34-20250527","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.clcc.2016.09.012","article-title":"The role of cyclooxygenase-2 in colorectal carcinogenesis.","volume":"16","author":"Liu","year":"2017","journal-title":"Clin Colorectal Cancer"},{"key":"R35-20250527","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.2174\/138945011798184218","article-title":"Cyclooxygenase as a target for colorectal cancer chemoprevention.","volume":"12","author":"Moreira","year":"2011","journal-title":"Curr Drug Targets"},{"key":"R36-20250527","first-page":"366","article-title":"The effectiveness of FOBT vs. FIT: a meta-analysis on colorectal cancer screening test.","volume":"30","author":"Mousavinezhad","year":"2016","journal-title":"Med J Islam Repub Iran"},{"key":"R37-20250527","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/AJP.0000000000000457","article-title":"Characterization of the adverse effects induced by acetaminophen and nonsteroidal anti-inflammatory drugs based on the analysis of the Japanese adverse drug event report database.","volume":"33","author":"Nagai","year":"2017","journal-title":"Clin J Pain"},{"key":"R38-20250527","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/BF02051919","article-title":"Relationship between blood plasma prostaglandin E2 and liver and lung metastases in colorectal cancer.","volume":"33","author":"Narisawa","year":"1990","journal-title":"Dis Colon Rectum"},{"key":"R39-20250527","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF02056946","article-title":"Tissue prostaglandin levels in familial adenomatous polyposis patients treated with sulindac.","volume":"39","author":"Nugent","year":"1996","journal-title":"Dis Colon Rectum"},{"key":"R40-20250527","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/djq031","article-title":"Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology.","volume":"102","author":"Ogino","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R41-20250527","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/gut.2010.217182","article-title":"Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.","volume":"60","author":"Ogino","year":"2011","journal-title":"Gut"},{"key":"R42-20250527","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00281-012-0353-5","article-title":"The role of PGE2-associated inflammatory responses in gastric cancer development.","volume":"35","author":"Oshima","year":"2013","journal-title":"Semin Immunopathol"},{"key":"R43-20250527","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1124\/jpet.110.173278","article-title":"The effects of the stromal cell-derived cyclooxygenase-2 metabolite prostaglandin E2 on the proliferation of colon cancer cells.","volume":"336","author":"Park","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"R44-20250527","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1517\/14740338.4.2.157","article-title":"Gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs.","volume":"4","author":"Peng","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"R45-20250527","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/gut.35.5.675","article-title":"Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2.","volume":"35","author":"Pugh","year":"1994","journal-title":"Gut"},{"key":"R46-20250527","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1054\/mehy.1999.0023","article-title":"Is inhibition of cyclooxygenase required for the chemopreventive effect of nsaids in colon cancer? A model reconciling the current contradiction.","volume":"54","author":"Rigas","year":"2000","journal-title":"Med Hypotheses"},{"key":"R47-20250527","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-3-642-30331-9_7","article-title":"Aspirin in prevention of sporadic colorectal cancer: current clinical evidence and overall balance of risks and benefits.","volume":"191","author":"Rothwell","year":"2013","journal-title":"Recent Results Cancer Res"},{"key":"R48-20250527","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/ajg.2011.38","article-title":"Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.","volume":"106","author":"Ruder","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R49-20250527","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.gie.2011.10.024","article-title":"Colorectal cancers not detected by screening flexible sigmoidoscopy in the prostate, lung, colorectal, and ovarian cancer screening trial.","volume":"75","author":"Schoen","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"R50-20250527","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF02785699","article-title":"Ultralow concentrations of ibuprofen activate cell prostaglandin synthesis.","volume":"61","author":"Sergeeva","year":"1996","journal-title":"Appl Biochem Biotechnol"},{"key":"R51-20250527","doi-asserted-by":"crossref","first-page":"14287","DOI":"10.1074\/jbc.M313276200","article-title":"Prostaglandin E2 synergistically enhances receptor tyrosine kinase-dependent signaling system in colon cancer cells.","volume":"279","author":"Shao","year":"2004","journal-title":"J Biol Chem"},{"key":"R52-20250527","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016.","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R53-20250527","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0021-9673(01)94653-9","article-title":"Picogram measurement of prostaglandin E2 synthesis by gastric mucosa by high-performance liquid chromatography.","volume":"385","author":"Stein","year":"1987","journal-title":"J Chromatogr"},{"key":"R54-20250527","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.critrevonc.2016.08.010","article-title":"Stromal COX-2 signaling are correlated with colorectal cancer: a review.","volume":"107","author":"Su","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"R55-20250527","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1053\/j.gastro.2010.01.058","article-title":"Inflammation and colon cancer.","volume":"138","author":"Terzi\u0107","year":"2010","journal-title":"Gastroenterology"},{"key":"R56-20250527","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s00261-015-0501-1","article-title":"Errors in CT colonography.","volume":"40","author":"Trilisky","year":"2015","journal-title":"Abdom Imaging"},{"key":"R57-20250527","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ijc.30183","article-title":"Inflammatory bowel disease, cancer and medication: cancer risk in the Dutch population-based IBDSL cohort.","volume":"139","author":"van den Heuvel","year":"2016","journal-title":"Int J Cancer"},{"key":"R58-20250527","first-page":"1750","article-title":"Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis.","volume":"58","author":"Yang","year":"1998","journal-title":"Cancer Res"},{"key":"R59-20250527","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00262-007-0417-x","article-title":"Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner.","volume":"57","author":"Yaqub","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"R60-20250527","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/j.1440-1746.2009.06138.x","article-title":"Epidemiology of colorectal cancer in Asia.","volume":"24","author":"Yee","year":"2009","journal-title":"J Gastroenterol Hepatol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:05:23Z","timestamp":1748361923000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,20]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000583","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,20]]}}}